Brown Advisory’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$109K Sell
10,383
-377
-4% -$3.68K ﹤0.01% 1362
2025
Q4
$124K Sell
10,760
-1,000
-9% -$15.4K ﹤0.01% 1356
2025
Q3
$286K Hold
11,760
﹤0.01% 1221
2025
Q2
$193K Hold
11,760
﹤0.01% 1298
2025
Q1
$214K Sell
11,760
-5,100
-30% -$146K ﹤0.01% 1247
2024
Q4
$626K Sell
16,860
-97
-0.6% -$3.71K ﹤0.01% 937
2024
Q3
$543K Sell
16,957
-7,336
-30% -$407K ﹤0.01% 977
2024
Q2
$1.99M Hold
24,293
﹤0.01% 636
2024
Q1
$3.52M Buy
24,293
+4,330
+22% +$366K ﹤0.01% 549
2023
Q4
$1.84M Buy
19,963
+325
+2% +$33K ﹤0.01% 641
2023
Q3
$3.24M Buy
19,638
+5,592
+40% +$727K 0.01% 534
2023
Q2
$888K Buy
14,046
+5,495
+64% +$333K ﹤0.01% 778
2023
Q1
$290K Sell
8,551
-14,154
-62% -$739K ﹤0.01% 1034
2022
Q4
$1.31M Buy
22,705
+10,270
+83% +$634K ﹤0.01% 692
2022
Q3
$1.17M Buy
+12,435
New +$1.77M ﹤0.01% 677
2022
Q2
Sell
-580
Closed -$318K 1112
2022
Q1
$318K Buy
580
+126
+28% +$76.1K ﹤0.01% 955
2021
Q4
$300K Hold
454
﹤0.01% 1030
2021
Q3
$381K Sell
454
-423
-48% -$429K ﹤0.01% 887
2021
Q2
$1.11M Buy
877
+39
+5% +$44K ﹤0.01% 676
2021
Q1
$920K Sell
838
-66
-7% -$87.1K ﹤0.01% 723
2020
Q4
$1.29M Buy
+904
New +$964K ﹤0.01% 608

Other funds holding CDLX

Brown Advisory's CDLX Position: Q1 2026 in Review

Brown Advisory reduced its Cardlytics (CDLX) stake by 3.5% in Q1 2026, selling an estimated $3.68K and leaving 10,383 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #1362.

Brown Advisory first reported a position in CDLX in Q4 2020 and has held it in 21 quarters since. The position peaked at $3.52M in Q1 2024. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Brown Advisory held 10,383 shares of Cardlytics worth $109K as of Q1 2026.
  • Brown Advisory sold 377 Cardlytics shares in Q1 2026, an estimated $3.68K.
  • Cardlytics made up ﹤0.01% of Brown Advisory's portfolio in Q1 2026, its #1362 holding.
  • Brown Advisory first reported a position in Cardlytics in Q4 2020 and has held it in 21 quarters since.
  • Brown Advisory's Cardlytics position peaked at $3.52M in Q1 2024.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.